Vanguard Group’s GT Biopharma GTBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.6K | Hold |
10,504
| – | – | ﹤0.01% | 4212 |
|
|
2025
Q1 | $23.5K | Hold |
10,504
| – | – | ﹤0.01% | 4234 |
|
|
2024
Q4 | $32K | Hold |
10,504
| – | – | ﹤0.01% | 4237 |
|
|
2024
Q3 | $24.1K | Hold |
10,504
| – | – | ﹤0.01% | 4291 |
|
|
2024
Q2 | $29.7K | Sell |
10,504
-10,008
| -49% | -$28.3K | ﹤0.01% | 4335 |
|
|
2024
Q1 | $90.9K | Sell |
20,512
-1,067,481
| -98% | -$4.73M | ﹤0.01% | 4253 |
|
|
2023
Q4 | $277K | Buy |
1,087,993
+759
| +0.1% | +$194 | ﹤0.01% | 4172 |
|
|
2023
Q3 | $262K | Sell |
1,087,234
-12,120
| -1% | -$2.92K | ﹤0.01% | 4202 |
|
|
2023
Q2 | $343K | Sell |
1,099,354
-28,051
| -2% | -$8.75K | ﹤0.01% | 4213 |
|
|
2023
Q1 | $620K | Hold |
1,127,405
| – | – | ﹤0.01% | 4060 |
|
|
2022
Q4 | $999K | Buy |
1,127,405
+464
| +0% | +$411 | ﹤0.01% | 3916 |
|
|
2022
Q3 | $1.98M | Buy |
1,126,941
+100
| +0% | +$176 | ﹤0.01% | 3745 |
|
|
2022
Q2 | $3.37M | Buy |
1,126,841
+138,899
| +14% | +$415K | ﹤0.01% | 3570 |
|
|
2022
Q1 | $2.85M | Sell |
987,942
-218,410
| -18% | -$629K | ﹤0.01% | 3800 |
|
|
2021
Q4 | $3.68M | Buy |
1,206,352
+243,029
| +25% | +$741K | ﹤0.01% | 3780 |
|
|
2021
Q3 | $6.49M | Sell |
963,323
-18,946
| -2% | -$128K | ﹤0.01% | 3500 |
|
|
2021
Q2 | $15.2M | Buy |
982,269
+714,605
| +267% | +$11.1M | ﹤0.01% | 2984 |
|
|
2021
Q1 | $1.83M | Buy |
+267,664
| New | +$1.83M | ﹤0.01% | 3880 |
|